Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma

NCT04314245 · clinicaltrials.gov ↗

COMPLETED

Status

1170

Enrollment

INDUSTRY

Sponsor class

Conditions

Urothelial Carcinoma
Bladder Cancer

Interventions

OTHER: Active Comparator: Pathology
OTHER: Active Comparator: Clinical Diagnosis
OTHER: Active Comparator: Clinical diagnosis
OTHER: Genetic test: AnchorDx's urine DNA methylation/somatic mutation profiling assay

Sponsor

AnchorDx Medical Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]